A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico

American Journal of Tropical Medicine and Hygiene - United States

doi 10.4269/ajtmh.14-0625